Chloroquine and hydroxychloroquine in covid-19

BMJ. 2020 Apr 8;369:m1432. doi: 10.1136/bmj.m1432.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents* / adverse effects
  • Antiviral Agents* / therapeutic use
  • Betacoronavirus / drug effects*
  • COVID-19
  • Chloroquine* / adverse effects
  • Chloroquine* / therapeutic use
  • Clinical Trials as Topic
  • Coronavirus Infections / drug therapy*
  • Drug Evaluation, Preclinical
  • Endpoint Determination
  • Humans
  • Hydroxychloroquine* / adverse effects
  • Hydroxychloroquine* / therapeutic use
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Research Design
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Hydroxychloroquine
  • Chloroquine

Supplementary concepts

  • COVID-19 drug treatment